Akhilesh Mishra

Supernumerary Philadelphia Positive

N. Pathak, Akhilesh Mishra, 2017 .

Prospective study of emergency presentation of abdominal tuberculosis

V. Deshmukh, D. D. Thorat, Akhilesh Mishra, 2017 .

Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics

Jamie B. Spangler, E. Jaffee, E. Gabrielson, 2021, Proceedings of the National Academy of Sciences.

Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma.

J. Brugarolas, A. Christie, E. Plimack, 2021, European Urology.

Gallium-68–labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics

E. Gabrielson, R. Dannals, S. Nimmagadda, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

A GALLIUM-68-LABELED PEPTIDE RADIOTRACER FOR CD38-TARGETED IMAGING IN MULTIPLE MYELOMA WITH PET

S. Nimmagadda, R. Hobbs, I. Marsh, 2023, bioRxiv.

PET/MRI and Bioluminescent Imaging Identify Hypoxia as a Cause of Programmed Cell Death Ligand 1 Image Heterogeneity.

B. Krishnamachary, M. Solaiyappan, M. McMahon, 2023, Radiology. Imaging cancer.

Expression of B lymphocyte antigen in pediatric B-cell precursor acute lymphoblastic leukemia: AIIMS Experience

R. Seth, N. Pathak, Akhilesh Mishra, 2016 .

Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1.

Seth D. Ludwig, K. Lidke, M. Wester, 2024, Cell chemical biology.

CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

S. Nimmagadda, Kuldeep Gupta, Gabriela Lofland, 2024, Advanced science.

A Gallium-68-Labeled Peptide Radiotracer For CD38-Targeted Imaging In Multiple Myeloma With PET

S. Nimmagadda, R. Hobbs, I. Marsh, 2023, bioRxiv.